Is Stoke Therapeutics, Inc. (STOK) a Buy, Sell, or Hold?
Stoke Therapeutics, Inc.
NASDAQ:STOK
$29.13 USD
-$0.33 (-1.12%)
- Volume
- 560.3K
- Average Volume
- 709.65K
- Market Capitalization
- $1.81B
- P/E Ratio
- -10.29
- Dividend Yield
- 0.00%
- Price Target
- $44.00
- Year High
- $40.22
- Year Low
- $11.66
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $8.99
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
49
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
115
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 1.08M
STOK Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
STOK Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | 2026-07-01 | S-Sale | 32.615 | 2026-07-06 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | 2026-07-01 | S-Sale | 33.2678 | 2026-07-06 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | 2026-06-16 | S-Sale | 29.95 | 2026-06-18 |
| TZIANABOS ARTHUR | director | 2026-06-03 | A-Award | 29.46 | 2026-06-05 |
| Smith Julie | director | 2026-06-03 | A-Award | 29.46 | 2026-06-05 |
| LEVIN ARTHUR A | director | 2026-06-03 | A-Award | 29.46 | 2026-06-05 |
| Krainer Adrian R. | director | 2026-06-03 | A-Award | 29.46 | 2026-06-05 |
| Kaye Edward M. MD | director | 2026-06-03 | A-Award | 29.46 | 2026-06-05 |
| Harrison Seth Loring | director | 2026-06-03 | A-Award | 29.46 | 2026-06-05 |
| Burstein Jennifer | director | 2026-06-03 | A-Award | 29.46 | 2026-06-05 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | 2026-06-01 | S-Sale | 30.58 | 2026-06-03 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | 2026-05-01 | S-Sale | 32.79 | 2026-05-05 |
| Kahn Clare | director | 2026-04-03 | A-Award | 32.79 | 2026-04-07 |
| Kahn Clare | 2026-04-03 | 0 | 2026-04-07 | ||
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | 2026-04-01 | S-Sale | 32.66 | 2026-04-03 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | 2026-03-20 | S-Sale | 33.6354 | 2026-03-24 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | 2026-03-20 | S-Sale | 34.4079 | 2026-03-24 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | 2026-03-19 | M-Exempt | 2.19 | 2026-03-19 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | 2026-03-17 | S-Sale | 32.7394 | 2026-03-19 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | 2026-03-17 | S-Sale | 33.3754 | 2026-03-19 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | 2026-03-19 | M-Exempt | 2.19 | 2026-03-19 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | 2026-03-18 | S-Sale | 31.2838 | 2026-03-19 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | 2026-03-18 | S-Sale | 31.7888 | 2026-03-19 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | 2026-03-18 | S-Sale | 32.85 | 2026-03-19 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | 2026-03-19 | S-Sale | 29.99 | 2026-03-19 |
| Leggett Thomas | officer: Chief Financial Officer | 2026-03-17 | S-Sale | 32.7394 | 2026-03-19 |
| Leggett Thomas | officer: Chief Financial Officer | 2026-03-17 | S-Sale | 33.3754 | 2026-03-19 |
| Leggett Thomas | officer: Chief Financial Officer | 2026-03-18 | S-Sale | 31.2838 | 2026-03-19 |
| Leggett Thomas | officer: Chief Financial Officer | 2026-03-18 | S-Sale | 31.7888 | 2026-03-19 |
| Leggett Thomas | officer: Chief Financial Officer | 2026-03-18 | S-Sale | 32.85 | 2026-03-19 |
| Hoitt Jason | officer: Chief Patient Officer | 2026-03-17 | S-Sale | 32.7394 | 2026-03-19 |
| Hoitt Jason | officer: Chief Patient Officer | 2026-03-17 | S-Sale | 33.3754 | 2026-03-19 |
| Hoitt Jason | officer: Chief Patient Officer | 2026-03-18 | S-Sale | 31.2838 | 2026-03-19 |
| Hoitt Jason | officer: Chief Patient Officer | 2026-03-18 | S-Sale | 31.7888 | 2026-03-19 |
| Hoitt Jason | officer: Chief Patient Officer | 2026-03-18 | S-Sale | 32.85 | 2026-03-19 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | 2026-03-17 | S-Sale | 32.7394 | 2026-03-19 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | 2026-03-17 | S-Sale | 33.3754 | 2026-03-19 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | 2026-03-18 | S-Sale | 31.2838 | 2026-03-19 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | 2026-03-18 | S-Sale | 31.7888 | 2026-03-19 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | 2026-03-18 | S-Sale | 32.85 | 2026-03-19 |
| Hoitt Jason | officer: Chief Patient Officer | 2026-03-15 | M-Exempt | 0 | 2026-03-17 |
| Hoitt Jason | officer: Chief Patient Officer | 2026-03-15 | M-Exempt | 0 | 2026-03-17 |
| Leggett Thomas | officer: Chief Financial Officer | 2026-03-15 | M-Exempt | 0 | 2026-03-17 |
| Leggett Thomas | officer: Chief Financial Officer | 2026-03-15 | M-Exempt | 0 | 2026-03-17 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | 2026-03-15 | M-Exempt | 0 | 2026-03-17 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | 2026-03-15 | M-Exempt | 0 | 2026-03-17 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | 2026-03-15 | M-Exempt | 0 | 2026-03-17 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | 2026-03-15 | M-Exempt | 0 | 2026-03-17 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | 2026-03-15 | M-Exempt | 0 | 2026-03-17 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | 2026-03-15 | M-Exempt | 0 | 2026-03-17 |
| Kaye Edward M. MD | director | 2026-03-15 | M-Exempt | 0 | 2026-03-17 |
| Kaye Edward M. MD | director | 2026-03-15 | M-Exempt | 0 | 2026-03-17 |
| Kaye Edward M. MD | director | 2026-03-15 | M-Exempt | 0 | 2026-03-17 |
| Kaye Edward M. MD | director | 2026-03-15 | M-Exempt | 0 | 2026-03-17 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | 2026-03-15 | M-Exempt | 0 | 2026-03-17 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | 2026-03-15 | M-Exempt | 0 | 2026-03-17 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | 2026-03-15 | M-Exempt | 0 | 2026-03-17 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | 2026-03-15 | M-Exempt | 0 | 2026-03-17 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | 2026-03-15 | M-Exempt | 0 | 2026-03-17 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | 2026-03-15 | M-Exempt | 0 | 2026-03-17 |
| LEVIN ARTHUR A | director | 2026-03-13 | S-Sale | 36.8 | 2026-03-17 |
| TZIANABOS ARTHUR | director, officer: Interim Executive Chair | 2026-03-10 | M-Exempt | 8.33 | 2026-03-12 |
| TZIANABOS ARTHUR | director, officer: Interim Executive Chair | 2026-03-10 | M-Exempt | 8.33 | 2026-03-12 |
| TZIANABOS ARTHUR | director, officer: Interim Executive Chair | 2026-03-10 | S-Sale | 40.0033 | 2026-03-12 |
| Krainer Adrian R. | director | 2026-03-10 | S-Sale | 39.7366 | 2026-03-12 |
| Krainer Adrian R. | director | 2026-03-02 | S-Sale | 39.6618 | 2026-03-04 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | 2026-02-17 | A-Award | 31.09 | 2026-02-19 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | 2026-02-17 | A-Award | 0 | 2026-02-19 |
| SMITH IAN F | director, officer: Chief Executive Officer | 2026-02-17 | A-Award | 31.09 | 2026-02-19 |
| SMITH IAN F | director, officer: Chief Executive Officer | 2026-02-17 | A-Award | 0 | 2026-02-19 |
| Leggett Thomas | officer: Chief Financial Officer | 2026-02-17 | A-Award | 31.09 | 2026-02-19 |
| Leggett Thomas | officer: Chief Financial Officer | 2026-02-17 | A-Award | 0 | 2026-02-19 |
| Hoitt Jason | officer: Chief Patient Officer | 2026-02-17 | A-Award | 31.09 | 2026-02-19 |
| Hoitt Jason | officer: Chief Patient Officer | 2026-02-17 | A-Award | 0 | 2026-02-19 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | 2026-02-17 | A-Award | 31.09 | 2026-02-19 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | 2026-02-17 | A-Award | 0 | 2026-02-19 |
| LEVIN ARTHUR A | director | 2025-12-31 | M-Exempt | 0 | 2026-01-05 |
| LEVIN ARTHUR A | director | 2025-12-31 | M-Exempt | 0 | 2026-01-05 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | 2025-12-08 | S-Sale | 31.5956 | 2025-12-10 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | 2025-12-08 | S-Sale | 32.6128 | 2025-12-10 |
| Kaye Edward M. MD | director | 2025-12-08 | S-Sale | 31.4387 | 2025-12-10 |
| Kaye Edward M. MD | director | 2025-12-08 | S-Sale | 32.52 | 2025-12-10 |
| Kaye Edward M. MD | director | 2025-12-08 | S-Sale | 33.1041 | 2025-12-10 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | 2025-12-03 | M-Exempt | 0 | 2025-12-05 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | 2025-12-04 | S-Sale | 30.7635 | 2025-12-05 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | 2025-12-04 | S-Sale | 31.3164 | 2025-12-05 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | 2025-12-05 | S-Sale | 31.3304 | 2025-12-05 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | 2025-12-05 | S-Sale | 31.3453 | 2025-12-05 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | 2025-12-03 | M-Exempt | 0 | 2025-12-05 |
| Kaye Edward M. MD | director | 2025-12-03 | M-Exempt | 0 | 2025-12-05 |
| Kaye Edward M. MD | director | 2025-12-04 | S-Sale | 30.7635 | 2025-12-05 |
| Kaye Edward M. MD | director | 2025-12-04 | S-Sale | 31.3164 | 2025-12-05 |
| Kaye Edward M. MD | director | 2025-12-05 | S-Sale | 31.3304 | 2025-12-05 |
| Kaye Edward M. MD | director | 2025-12-05 | S-Sale | 31.1468 | 2025-12-05 |
| Kaye Edward M. MD | director | 2025-12-05 | S-Sale | 31.846 | 2025-12-05 |
| Kaye Edward M. MD | director | 2025-12-03 | M-Exempt | 0 | 2025-12-05 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | 2025-12-03 | M-Exempt | 0 | 2025-12-05 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | 2025-12-04 | S-Sale | 30.7635 | 2025-12-05 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | 2025-12-04 | S-Sale | 31.3164 | 2025-12-05 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | 2025-12-05 | S-Sale | 31.3304 | 2025-12-05 |